tiprankstipranks
Trending News
More News >
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market

Compare Prime Medicine, Inc. (PRME) vs. Competitors

Compare
855 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Prime Medicine, Inc.
$3.98
$718.43M
-2.70
38.68%
4 Buy
3 Hold
0 Sell
Moderate Buy
Immatics
$9.83
$1.32B
-8.99
84.08%
6 Buy
0 Hold
0 Sell
Strong Buy
Relay Therapeutics
$7.35
$1.27B
-4.20
70.14%
5 Buy
1 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$4.56
$1.25B
-12.86
188.61%
10 Buy
0 Hold
0 Sell
Strong Buy
Sana Biotechnology
$4.58
$1.22B
-4.72
40.92%
4 Buy
0 Hold
0 Sell
Strong Buy
Upstream Bio, Inc.
$26.97
$1.68B
-13.57
184.93%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRME
Prime Medicine, Inc.
3.98
1.07
36.77%
IMTX
Immatics
9.83
4.43
82.04%
RLAY
Relay Therapeutics
7.35
2.69
57.73%
TSHA
Taysha Gene Therapies
4.56
3.03
198.04%
SANA
Sana Biotechnology
4.58
1.66
56.85%
UPB
Upstream Bio, Inc.
31.00
20.19
186.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts